» Articles » PMID: 19898183

Enhanced Depth Imaging Optical Coherence Tomography of the Choroid in Central Serous Chorioretinopathy

Overview
Journal Retina
Date 2009 Nov 10
PMID 19898183
Citations 325
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The purpose of the study was to evaluate the choroidal thickness in patients with central serous chorioretinopathy, a disease attributed to increased choroidal vascular hyperpermeability.

Methods: Patients with central serous chorioretinopathy underwent enhanced depth imaging spectral-domain optical coherence tomography, which was obtained by positioning a spectral-domain optical coherence tomography device close enough to the eye to acquire an inverted image. Seven sections, each comprising 100 averaged scans, were obtained within a 5 degrees x 30 degrees rectangle to encompass the macula. The subfoveal choroidal thickness was measured from the outer border of the retinal pigment epithelium to the inner scleral border.

Results: The mean age of subjects undergoing enhanced depth imaging spectral-domain optical coherence tomography was 59.3 years (standard deviation, 15.8 years). Seventeen of 19 patients (89.5%) were men, and 12 (63.2%) patients had bilateral clinical disease. The choroidal thickness measured in 28 eligible eyes of the 19 patients was 505 microm (standard deviation, 124 microm), which was significantly greater than the choroidal thickness in normal eyes (P < or = 0.001).

Conclusion: Enhanced depth imaging spectral-domain optical coherence tomography demonstrated a very thick choroid in patients with central serous chorioretinopathy. This finding provides additional evidence that central serous chorioretinopathy may be caused by increased hydrostatic pressure in the choroid.

Citing Articles

Choroidal vascularity ındex findings ın patients recovered from mild course COVID-19 pneumonia.

Toprak M, Kesim E, Karasu B, Celebi A Int Ophthalmol. 2025; 45(1):84.

PMID: 40045062 DOI: 10.1007/s10792-025-03450-4.


Choroidal Response to Intravitreal Bevacizumab Injections in Treatment-Naïve Macular Neovascularization Secondary to Chronic Central Serous Chorioretinopathy.

Rabinovitch D, Shulman S, Goldenberg D, Wang L, Iyer P, Loewenstein A Biomedicines. 2025; 12(12.

PMID: 39767667 PMC: 11673265. DOI: 10.3390/biomedicines12122760.


Influence of Aflibercept on Choroidal Blood Flow and Thickness in Branch Retinal Vein Occlusion: A Six-Month Follow-Up Study.

Hashimoto R, Aso K, Yata K, Tanaka K, Fujioka N, Yamazaki R Diagnostics (Basel). 2024; 14(22).

PMID: 39594150 PMC: 11593557. DOI: 10.3390/diagnostics14222484.


Optical Coherence Tomography Study of Choroidal Response to Exercise-Induced Hypertension in Chronic Central Serous Chorioretinopathy.

Samanta A, Gregori G, Muzi A, Gujar R, Mariotti C, Fruttini D J Clin Med. 2024; 13(21).

PMID: 39518719 PMC: 11545873. DOI: 10.3390/jcm13216580.


Importance of OCT-derived biomarkers for the recurrence of central serous chorioretinopathy using statistics and predictive modelling.

Seiler E, Delachaux L, Cattaneo J, Garjani A, Martin T, Duriez A Sci Rep. 2024; 14(1):23940.

PMID: 39397115 PMC: 11471761. DOI: 10.1038/s41598-024-75275-7.